EEG Recordings as Biomarkers of Pain Perception: Where Do We Stand and Where to Go?

被引:26
|
作者
Zis, Panagiotis [1 ,2 ,3 ]
Liampas, Andreas [3 ]
Artemiadis, Artemios [1 ,3 ]
Tsalamandris, Gabriela [1 ]
Neophytou, Panagiota [3 ]
Unwin, Zoe [4 ]
Kimiskidis, Vasilios K. [5 ]
Hadjigeorgiou, Georgios M. [1 ,3 ]
Varrassi, Giustino [6 ]
Zhao, Yifan [7 ]
Sarrigiannis, Ptolemaios Georgios [2 ]
机构
[1] Univ Cyprus, Med Sch, Nicosia, Cyprus
[2] Univ Sheffield, Med Sch, Sheffield, S Yorkshire, England
[3] Nicosia Gen Hosp, Dept Neurol, Nicosia, Cyprus
[4] Sheffield Teaching Hosp NHS Fdn Trust, Dept Clin Neurophysiol, Sheffield, S Yorkshire, England
[5] Aristotle Univ Thessaloniki, Dept Neurol 1, AHEPA Univ Hosp, Sch Med, Thessaloniki, Greece
[6] Paolo Procacci Fdn, Rome, Italy
[7] Cranfield Univ, Sch Aerosp Transport & Mfg, Cranfield, Beds, England
关键词
EEG; Electroencephalogram; Pain; Perception; Biomarker; EXPERIMENTAL MUSCLE PAIN; OSCILLATORY ACTIVITY; THETA OSCILLATIONS; BRAIN; STIMULATION; COLD; RESPONSES; POWER; CONNECTIVITY; ACTIVATION;
D O I
10.1007/s40122-022-00372-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction The universality and complexity of pain, which is highly prevalent, yield its significance to both patients and researchers. Developing a non-invasive tool that can objectively measure pain is of the utmost importance for clinical and research purposes. Traditionally electroencephalography (EEG) has been mostly used in epilepsy; however, over the recent years EEG has become an important non-invasive clinical tool that has helped increase our understanding of brain network complexities and for the identification of areas of dysfunction. This review aimed to investigate the role of EEG recordings as potential biomarkers of pain perception. Methods A systematic search of the PubMed database led to the identification of 938 papers, of which 919 were excluded as a result of not meeting the eligibility criteria, and one article was identified through screening of the reference lists of the 19 eligible studies. Ultimately, 20 papers were included in this systematic review. Results Changes of the cortical activation have potential, though the described changes are not always consistent. The most consistent finding is the increase in the delta and gamma power activity. Only a limited number of studies have looked into brain networks encoding pain perception. Conclusion Although no robust EEG biomarkers of pain perception have been identified yet, EEG has potential and future research should be attempted. Designing strong research protocols, controlling for potential risk of biases, as well as investigating brain networks rather than isolated cortical changes will be crucial in this attempt.
引用
收藏
页码:369 / 380
页数:12
相关论文
共 50 条
  • [1] EEG Recordings as Biomarkers of Pain Perception: Where Do We Stand and Where to Go?
    Panagiotis Zis
    Andreas Liampas
    Artemios Artemiadis
    Gabriela Tsalamandris
    Panagiota Neophytou
    Zoe Unwin
    Vasilios K. Kimiskidis
    Georgios M. Hadjigeorgiou
    Giustino Varrassi
    Yifan Zhao
    Ptolemaios Georgios Sarrigiannis
    Pain and Therapy, 2022, 11 : 369 - 380
  • [2] Biomarkers, Where Do We Stand
    Dixit, Vikash
    Sharma, Payal
    Dhage, Atul Dyandeo
    INDIAN JOURNAL OF PSYCHIATRY, 2015, 57 (05) : S165 - S166
  • [3] Cardiac biomarkers in patients suspected of acute myocardial infarction: Where do we stand and where do we go?
    Meune, Christophe
    Aiessou, Linda
    Sorbets, Emmanuel
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2014, 107 (12) : 643 - 645
  • [4] Vascularization in skin wound healing: where do we stand and where do we go
    Moreira, Helena R.
    Marques, Alexandra P.
    CURRENT OPINION IN BIOTECHNOLOGY, 2022, 73 : 253 - 262
  • [5] Implementation of Psychologically Informed Physical Therapy for Low Back Pain: Where Do We Stand, Where Do We Go?
    Ballengee, Lindsay A.
    Zullig, Leah L.
    George, Steven Z.
    JOURNAL OF PAIN RESEARCH, 2021, 14 : 3747 - 3757
  • [6] Biomarkers for cancer cachexia: where do we stand?
    Palus, Sandra
    Springer, Jochen
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2020, 11 (06) : 1388 - 1389
  • [7] Biomarkers to guide immunomodulatory treatment: where do we stand?
    Kyriazopoulou, Evdoxia
    Giamarellos-Bourboulis, Evangelos J.
    Akinosoglou, Karolina
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2023, 23 (11) : 945 - 958
  • [8] In search of a composite biomarker for chronic pain by way of EEG and machine learning: where do we currently stand?
    Rockholt, Mika M.
    Kenefati, George
    Doan, Lisa V.
    Chen, Zhe Sage
    Wang, Jing
    FRONTIERS IN NEUROSCIENCE, 2023, 17
  • [9] Targeting Oxidative Stress for Disease Prevention and Therapy: Where Do We Stand, and Where Do We Go from Here
    Vassalle, Cristina
    Maltinti, Maristella
    Sabatino, Laura
    MOLECULES, 2020, 25 (11):
  • [10] Personalized therapy in pain management: where do we stand?
    Stamer, Ulrike M.
    Zheng, Lan
    Stueber, Frank
    PHARMACOGENOMICS, 2010, 11 (06) : 843 - 864